Qube Research & Technologies (QRT)
INKT icon

Qube Research & Technologies (QRT)’s MiNK Therapeutics INKT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INKT Stock Details INKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-194
Closed -$1.84K – 3696
2024
Q2 		$1.84K Hold
194
– – ﹤0.01% 3194
2024
Q1 		$1.76K Hold
194
– – ﹤0.01% 4003
2023
Q4 		$2.09K Hold
194
– – ﹤0.01% 3815
2023
Q3 		$2.27K Buy
+194
New +$3.16K ﹤0.01% 3558

Other funds holding INKT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LF
Longbow Finance Lutry, Switzerland $552M AUM 40.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INKT Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of MiNK Therapeutics (INKT) in Q3 2024, closing a stake of 194 shares — an estimated $1.84K sold.

Qube Research & Technologies (QRT) first reported a position in INKT in Q3 2023 and held it in 4 quarters. The position peaked at $2.27K in Q3 2023. 24 funds tracked by Wall St. Rank hold INKT as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining MiNK Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 194 MiNK Therapeutics shares in Q3 2024, an estimated $1.84K.
  • Qube Research & Technologies (QRT) first reported a position in MiNK Therapeutics in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s MiNK Therapeutics position peaked at $2.27K in Q3 2023.
  • 24 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.